1,2,3-三醇连接的螺旋[氨酸-氧化]衍生物在人类肝瘤细胞中诱导抗癌作用
Shashikala Mariswamy Rajesh1, Prasanna Doddakunche Shivaramu2,3, Chandra Sekhar Bhol3
1Department of Studies in Chemistry, University of Mysore, Manasagangotri, Mysuru, India.
Chemical biology & drug design
|March 26, 2025
概括
新型环氧化衍生物对肝癌细胞表现出强大的抗癌活性. 化合物RR-01和RR-07被确定为有前途的细胞毒剂,诱导肝细胞癌 (HCC) 细胞的亡和自.
科学领域:
- 药用化学 医学化学
- 有机合成 有机合成
- 癌症生物学 癌症生物学
背景情况:
- 环氧化物以其抗癌特性而闻名.
- 肝细胞癌 (HCC) 仍然是一个重大的全球健康挑战.
- 开发用于HCC的新型,有效的治疗剂至关重要.
研究的目的:
- 为了合成新型的spiro[indoline-3,2'-oxiran]-2-one衍生物.
- 为了评估这些衍生物对HCC细胞系的抗癌作用.
- 为了识别具有强大的细胞毒性活性的化合物.
主要方法:
- 新型环氧化衍生物的合成通过硫化与1,2,3-triazole-tethered isatins的区域选择性反应.
- 通过细胞活力测试 (HepG2和HCCLM3细胞) 进行体外评估.
- 对抗癌症机制的评估,包括殖民地形成,迁移,亡和自测试.
主要成果:
- 成功合成了新的3'-phenyl-1-((1-aryl-1H-1,2,3-triazol-5-yl) methyl) spiro[indoline-3,2'-oxiran]-2-one衍生物的成功合成.
- 化合物RR-01和RR-07对HepG2和HCCLM3细胞表现出显著的细胞毒性.
- 这些化合物抑制了殖民地形成和细胞迁移,并诱导了亡和自.
结论:
- 合成的新型环氧化衍生物对HCC具有有前途的抗癌活性.
- RR-01和RR-07被确定为强大的化合物,需要进一步调查.
- 这些化合物通过诱导肝癌细胞的亡和自来发挥其作用.
更多相关视频
10:33Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
Published on: October 26, 2015
11.3K
11:06Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro
Published on: January 31, 2022
4.3K
相关概念视频
Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
